SCOPUS 정보 검색 플랫폼

Volumn 38, Issue SUPPL. 4, 2002, Pages 142-146

Regulatory issues for clinical trials at EORTC: The way forward

Author keywords

Clinical Trial Regulatory Affairs; European policy

Indexed keywords

ARTICLE; CANCER RESEARCH; CLINICAL TRIAL; EUROPE; HEALTH CARE POLICY; MEDICAL SOCIETY; METHODOLOGY; PRIORITY JOURNAL;

EID: 0036180915 PISSN: 09598049 EISSN: None Source Type: Journal
DOI: 10.1016/s0959-8049(01)00443-9 Document Type: Article

Times cited : (2)

References (4)

1
- 2042427329
- Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. EC 2001/20 L121/34 (hereinafter referred to as 'Directive new clinical trials)

2
- 2042520304
- SAE report handling in a multinational academic research environment
- April
- (2000) Appl Clin Trials , pp. 38-45
- Dubois, N.¹ Lacombe, D.²

3
- 0031817874
- Obstacles for independent transnational clinical trials in Europe
- (1998) Int J Pharm Med , vol.12 , pp. 133-136
- Lacombe, D.¹ Therasse, P.² Meunier, F.³

4
- 2042489873
- Insuring clinical trials, an academic viewpoint
- March
- (1998) Appl Clin Trials
- Lacombe, D.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.